10.01.15
American Medical Holdings, New York, NY, in association with Japan Bioactives has launched FB3 Fusion Ingredient Beverage for the weight management category.
"In addition to our FB3 tablets, the interest in foods and beverages containing healthy ingredients has led to development of FB3 Fusion Ingredient in form of on-the-go shot drink with pomegranate in a 50 ml serving size," says Vladimir Badmaev, MD, PhD, CEO of American Medical Holdings and product inventor.
He added, "The objective for the FB3 beverage development has been to deliver more 'fun' to the consumer but with the solid and continuous science supported functionality. The ultimate goal has been to develop a product with good compliance and outstanding and proven quality in maintaining healthy weight. Versatility in product delivery is highly attractive to many consumers who may not want to constantly swallow pills or who cannot."
FB3 Fusion Ingredient is an herbal composition of Coleus forskohlii, Salacia reticulata, and Sesamum indicum, standardized for forskolin, salacinol, and sesamin, respectively. The ingredient was shown, in vitro, to inhibit pancreatic lipase with differing degrees and dynamics. The published study demonstrated that the formula’s botanicals synergistically prevented absorption of excess dietary fat (n-6 fatty acids are typically abundant in the Western diet). Hypothetically, preventing absorption of excess dietary fat and n-6 fatty acids may gradually normalize the overactive endocannabinoid system, thereby preventing obesity, especially if this approach is combined with consuming an n-3 fatty acids-rich diet, which competes with n-6 fatty acid absorption.
"In addition to our FB3 tablets, the interest in foods and beverages containing healthy ingredients has led to development of FB3 Fusion Ingredient in form of on-the-go shot drink with pomegranate in a 50 ml serving size," says Vladimir Badmaev, MD, PhD, CEO of American Medical Holdings and product inventor.
He added, "The objective for the FB3 beverage development has been to deliver more 'fun' to the consumer but with the solid and continuous science supported functionality. The ultimate goal has been to develop a product with good compliance and outstanding and proven quality in maintaining healthy weight. Versatility in product delivery is highly attractive to many consumers who may not want to constantly swallow pills or who cannot."
FB3 Fusion Ingredient is an herbal composition of Coleus forskohlii, Salacia reticulata, and Sesamum indicum, standardized for forskolin, salacinol, and sesamin, respectively. The ingredient was shown, in vitro, to inhibit pancreatic lipase with differing degrees and dynamics. The published study demonstrated that the formula’s botanicals synergistically prevented absorption of excess dietary fat (n-6 fatty acids are typically abundant in the Western diet). Hypothetically, preventing absorption of excess dietary fat and n-6 fatty acids may gradually normalize the overactive endocannabinoid system, thereby preventing obesity, especially if this approach is combined with consuming an n-3 fatty acids-rich diet, which competes with n-6 fatty acid absorption.